← Back to Search

EDITH-HC Training Tool for Dementia Care (EDITH-HC Trial)

N/A

Recruiting

Led By Elizabeth Luth, PhD

Research Sponsored by Rutgers, The State University of New Jersey

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months post-intervention, 6 months post-intervention

Awards & highlights

EDITH-HC Trial Summary

This trial will test a tool to help hospice clinicians better care for people with dementia & their family caregivers, to reduce caregiver burden & improve care.

Who is the study for?

This trial is for nurses, social workers, or family members aged 19-90 who care for someone with dementia in home hospice. Participants must speak English and identify as White or Black/African American. While gender isn't a factor for exclusion, it's anticipated that most participants will be female.Check my eligibility

What is being tested?

The study tests 'EDITH-HC', a training and tool designed to enhance dementia care by home hospice clinicians. It aims to see if this can reduce caregiver burden and increase clinicians' knowledge about dementia caregiving compared to usual care.See study design

What are the potential side effects?

Since the intervention involves educational material rather than medical treatment, traditional side effects are not applicable. However, there may be indirect effects on stress levels or emotional state of caregivers due to changes in caregiving practices.

EDITH-HC Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months post-intervention, 6 months post-intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months post-intervention, 6 months post-intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months post-intervention, 6 months post-intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Family Caregiver Burden

Secondary outcome measures

Clinician knowledge of dementia-related issues at end of life

Other outcome measures

Family caregiver preparedness (exploratory)

Family caregiver self-efficacy (exploratory)

Patient hospice discharge status (exploratory)

EDITH-HC Trial Design

2Treatment groups

Experimental Treatment

Group I: Intervention GroupExperimental Treatment1 Intervention

Clinicians in intervention group will watch a series educational and instructional videos and use caregiver burden assessment tool up to four times during regular home visits with family caregivers of home hospice patients living with dementia. Clinicians will be assessed for changes in knowledge regarding dementia caregiving (secondary outcome). Family caregivers will be assessed for changes in caregiver burden (primary outcome) and preparedness and self-efficacy (exploratory outcomes).

Group II: Control GroupExperimental Treatment1 Intervention

Clinicians in control group will listen to a presentation on outcomes for home hospice patients living with dementia. Clinicians will be assessed for changes in knowledge regarding dementia caregiving (secondary outcome). Family caregivers will be assessed for changes in caregiver burden (primary outcome) and preparedness and self-efficacy (exploratory outcomes).

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Rutgers, The State University of New JerseyLead Sponsor

429 Previous Clinical Trials

64,032 Total Patients Enrolled

National Institute on Aging (NIA)NIH

1,675 Previous Clinical Trials

28,020,685 Total Patients Enrolled

Elizabeth Luth, PhDPrincipal InvestigatorRutgers University

1 Previous Clinical Trials

450 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this trial only recruiting adults aged 25 and up?

"This research is actively seeking individuals aged 19 or older, yet younger than 90 years old."

Answered by AI

How many individuals are being administered care through this trial?

"Affirmative, the information on clinicaltrials.gov reveals this medical trial is actively enlisting patients. The study was originally advertised on October 6th 2023 and has been recently amended to reflect new updates as of November 16th 2023. 200 participants are required across 1 location for completion of the experiment."

Answered by AI

Has recruitment for this trial commenced?

"Affirmative. The information hosted on clinicaltrials.gov attests that this medical trial is actively recruiting patients; the listing was first published on October 6th 2023 and last updated November 16th of the same year. 200 participants are required from 1 designated site."

Answered by AI

Could I qualify for inclusion in this research project?

"This medical study is recruiting 200 participants, aged 19 to 90 years old who have caretakers. It is not a requirement that such individuals are of any specific gender and it's expected that 70-80% will be female due to the makeup of hospice workers and family caregivers. Furthermore, those selected must either be nurses, social workers or family members providing care for someone living with dementia enrolled in home hospice care; they should also speak English fluently so as to facilitate data collection. Finally, candidates can identify as White or Black/African American."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Pilot Testing Dementia-Enhanced Training and Tool for Home Hospice Clinicians

Elizabeth A. Luth, PhD 2023. "Pilot Testing Dementia-Enhanced Training and Tool for Home Hospice Clinicians". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05719077.

All > Alzheimers Disease New York